Home/Filings/4/0001562180-22-005708
4//SEC Filing

Etherington Robert Dee 4

Accession 0001562180-22-005708

CIK 0001822791other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 4:08 PM ET

Size

6.3 KB

Accession

0001562180-22-005708

Insider Transaction Report

Form 4
Period: 2022-07-18
Etherington Robert Dee
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2022-07-18$4.72/sh23,483$110,84056,593 total
Holdings
  • Common Stock

    (indirect: By LLC)
    12,717
Footnotes (2)
  • [F1]The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to be sold by Mr. Etherington to satisfy tax obligations in connection with the vesting of 80,076 restricted stock awards. The sales occurred automatically to satisfy tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan at a weighted average price of $4.72; the shares were sold in multiple transactions at prices ranging from $4.36 to $4.94, inclusive.
  • [F2]The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.

Issuer

Clene Inc.

CIK 0001822791

Entity typeother

Related Parties

1
  • filerCIK 0001835330

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:08 PM ET
Size
6.3 KB